Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
New England Journal of Medicine · 27.03.2025 · 392 (12) · 1155-1167
DOI: 10.1056/nejmoa2412006 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 27.03.2025. Verfasst von Yufang Bi und 46 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 234-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medi…
- Department of Endocrine and Metabolic Diseases, Third People's Hospital of Datong, Datong, China.
- Department of Endocrine and Metabolic Diseases, First People's Hospital of Loudi, Loudi, China.
- Department of Endocrine and Metabolic Diseases, Third Hospital of Nanchang, Nanchang, China.
- Department of Endocrine and Metabolic Diseases, General Hospital of Hebi Coal Industry Group, Hebi, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Bi, Y., Li, M., Liu, Y., Li, T., Lu, J., Duan, P., Xu, F., Dong, Q., Wang, A., Wang, T., Zheng, R., Chen, Y., Xu, M., Wang, X., Zhang, X., Niu, Y., Kang, Z., Lu, C., Wang, J., …, & BPROAD Research Group (2025). Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. New England Journal of Medicine, 392(12), 1155-1167. https://doi.org/10.1056/nejmoa2412006
Vancouver
Bi Y, Li M, Liu Y, Li T, Lu J, Duan P, et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. New England Journal of Medicine. 2025;392(12):1155-1167. doi:10.1056/nejmoa2412006
BibTeX
@article{Bi2025,
author = {Bi, Yufang and Li, Mian and Liu, Yan and Li, Tingzhi and Lu, Jieli and Duan, Peng and Xu, Fengmei and Dong, Qijuan and Wang, Ailiang and Wang, Tiange and Zheng, Ruizhi and Chen, Yuhong and Xu, Min and Wang, Xiaohu and Zhang, Xinhuan and Niu, Yanbo and Kang, Zhiqiang and Lu, Chunru and Wang, Jing and Qiu, Xinwen and Wang, An and Wu, Shujing and Niu, Jingya and Wang, Jingya and Zhao, Zhiyun and Pan, Huanfeng and Yang, Xiaohua and Niu, Xiaohong and Pang, Shuguang and Zhang, Xiaoliang and Dai, Yuancheng and Wan, Qin and Chen, Shihong and Zheng, Qidong and Dai, Shaoping and Deng, Juan and Liu, Leshan and Wang, Guixia and Zhu, Huiqi and Tang, Weidong and Liu, Haixia and Guo, Zhenfang and Ning, Guang and He, Jiang and Xu, Yu and Wang, Weiqing and BPROAD Research Group, BPROAD Research Group},
title = {Intensive Blood-Pressure Control in Patients with Type 2 Diabetes},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {12},
pages = {1155--1167},
doi = {10.1056/nejmoa2412006}
}
EUVIMED